Certainly, I can't speak to the outcomes yet, because the study is still under way, as you know, with the AFN, but we too have heard concerns about medical travel. As you know, we have worked with territories significantly on medical travel and we have supported the territories—you would know this as a former health official in a territory—with the significant cost burden that families and health care systems have faced for medical travel. This is work that I think is critically important.
To your point, there have been some really great outcomes since your study. One that I'm very excited about—I know we're running out of time, Mr. Chair—is the newfangled modern glucose monitors that are now fully covered for people who are managing their diabetes with insulin. We're matching provincial and territorial coverage. The reason I raise this is that I met some people in my community—health care practitioners, in fact—who talked about the game-changer this is for people's health outcomes. It's lessening the burden on health care systems, including reducing things like the need for medical travel for complex diabetes care, so it's—